DocGo Inc. (DCGO)
USD 4.29
(-2.39%)
USD 4.29
(-2.39%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 185.28 Million USD | 62.03% |
| 2022 | 114.35 Million USD | 38.53% |
| 2021 | 82.54 Million USD | 148.44% |
| 2020 | 33.22 Million USD | 53.81% |
| 2019 | 21.6 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 175.6 Million USD | -5.22% |
| 2024 Q2 | 170.17 Million USD | -3.09% |
| 2023 Q1 | 123.62 Million USD | 8.11% |
| 2023 FY | 185.28 Million USD | 62.03% |
| 2023 Q4 | 185.28 Million USD | 44.49% |
| 2023 Q3 | 128.23 Million USD | 20.49% |
| 2023 Q2 | 106.42 Million USD | -13.91% |
| 2022 Q2 | 77.46 Million USD | -8.8% |
| 2022 Q1 | 84.93 Million USD | 2.89% |
| 2022 FY | 114.35 Million USD | 38.53% |
| 2022 Q4 | 114.35 Million USD | 34.39% |
| 2022 Q3 | 85.08 Million USD | 9.84% |
| 2021 Q1 | 10.89 Million USD | -67.21% |
| 2021 FY | 82.54 Million USD | 148.44% |
| 2021 Q3 | 77.02 Million USD | 35.4% |
| 2021 Q2 | 56.88 Million USD | 422.19% |
| 2021 Q4 | 82.54 Million USD | 7.17% |
| 2020 Q1 | - USD | 0.0% |
| 2020 Q4 | 33.22 Million USD | 0.0% |
| 2020 FY | 33.22 Million USD | 53.81% |
| 2019 FY | 21.6 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.47 Billion USD | 92.502% |
| Addus HomeCare Corporation | 317.73 Million USD | 41.686% |
| AirSculpt Technologies, Inc. | 129.56 Million USD | -43.008% |
| Amedisys, Inc. | 940.38 Million USD | 80.297% |
| American Oncology Network, Inc. | 368.72 Million USD | 49.751% |
| Astrana Health, Inc. | 522.59 Million USD | 64.546% |
| Aveanna Healthcare Holdings Inc. | 1.76 Billion USD | 89.5% |
| IMAC Holdings, Inc. | 1.89 Million USD | -9668.258% |
| biote Corp. | 191.84 Million USD | 3.419% |
| Cryo-Cell International, Inc. | 72.25 Million USD | -156.437% |
| Cross Country Healthcare, Inc. | 205.92 Million USD | 10.025% |
| COMPASS Pathways plc | 50.24 Million USD | -268.77% |
| The Ensign Group, Inc. | 2.68 Billion USD | 93.087% |
| Healthcare Services Group, Inc. | 346.56 Million USD | 46.538% |
| InnovAge Holding Corp. | 247.85 Million USD | 25.246% |
| Assure Holdings Corp. | 22.84 Million USD | -710.893% |
| The Joint Corp. | 62.37 Million USD | -197.025% |
| LifeStance Health Group, Inc. | 804.27 Million USD | 76.963% |
| Mobile-health Network Solutions Class A Ordinary Shares | 3.81 Million USD | -4761.536% |
| ModivCare Inc. | 1.61 Billion USD | 88.5% |
| NewGenIvf Group Limited | 1.24 Million USD | -14824.744% |
| Novo Integrated Sciences, Inc. | 11.06 Million USD | -1574.634% |
| Option Care Health, Inc. | 1.9 Billion USD | 90.283% |
| P3 Health Partners Inc. | 427.3 Million USD | 56.64% |
| P3 Health Partners Inc. | 427.3 Million USD | 56.64% |
| The Pennant Group, Inc. | 394.17 Million USD | 52.995% |
| Surgery Partners, Inc. | 3.65 Billion USD | 94.934% |
| Syra Health Corp. Class A Common Stock | 910.07 Thousand USD | -20258.939% |
| Talkspace, Inc. | 23.57 Million USD | -685.922% |
| Talkspace, Inc. | 23.57 Million USD | -685.922% |
| The Oncology Institute, Inc. | 162.39 Million USD | -14.094% |
| The Oncology Institute, Inc. | 162.39 Million USD | -14.094% |